Tag: Heart / Stroke-Related: Stroke
Study Explores Link Between Weight and Stroke Risk in Women
Being overweight ups odds for ischemic stroke, but may slightly lower chances for hemorrhagic stroke
Warfarin Persistence Higher Than Previously Reported in A-Fib
Risk of discontinuation increased with previous intracranial bleeding, excessive alcohol use, anemia
Circulating Biomarkers May Be Indicative of Stroke Risk
High levels of CRP, tHcy, TNFR2, and VEGF indicate significantly higher odds for incident ischemic stroke
Stem Cells May Help Reverse Ischemic Stroke Damage
Experimental treatment helps new brain cells grow
Anemia Tied to Increased Mortality Risk Following Stroke
Higher mortality risk at multiple time points for up to one year after ischemic, hemorrhagic stroke
DAPT Use Variable in Patients With A-Fib at Risk of Stroke
Dual antiplatelet therapy used in variable manner; most patients remain on study drug after PCI
Pioglitazone Cuts Diabetes Risk After Ischemic Stroke, TIA
Findings for patients with recent ischemic stroke/TIA and insulin resistance, but no history of diabetes
Usual Apixaban Dosing OK With One Dose-Reduction Criterion
5 mg apixaban twice daily deemed safe, appropriate for those with one criterion in ARISTOTLE trial
Primary Stroke Centers Have Slight Survival Edge
Study finds small advantage, but only if patient gets there within 90 minutes
Clopidogrel Plus Aspirin Good for Noncarriers of CYP2C19 Variants
Reduction in risk of new stroke for clopidogrel plus aspirin in those not carrying loss-of-function alleles
